BioSpace News Archive

Press Releases

Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments

May 7, 2025
·
4 min read
Press Releases

Arbutus Presents Clinical Trial Data from its Two HBV Assets, Imdusiran and AB-101, at the European Association for the Study of the Liver (EASL) Congress 2025

May 7, 2025
·
8 min read
Press Releases

Dr. Falk Pharma announces positive results from its pivotal phase 3 trial on norucholic acid in primary sclerosing cholangitis

May 7, 2025
·
5 min read
Press Releases

Bluejay Therapeutics Reports First Preclinical Data for Liver-Targeted Fatty Acid Synthase (FASN) Inhibitor BJT-188 Being Investigated for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)

May 7, 2025
·
5 min read
Press Releases

Late-breaking exploratory data highlights the impact of IQIRVO® (elafibranor) on fatigue and provides mechanistic insights into anti-inflammatory and symptom-related effects in patients with primary biliary cholangitis

May 7, 2025
·
9 min read
Press Releases

Trogenix Further Strengthens its Scientific Advisory Board with the Appointment of World-Leading Experts, Prof Nada Jabado and Prof Burkhard Becher

May 7, 2025
·
3 min read
Press Releases

Spago Nanomedical Interim Report January-March, 2025

May 7, 2025
·
5 min read
Press Releases

The world’s first: Grand Pharma’s global innovative product STC3141 successfully reached the clinical endpoint in the Phase II clinical study in China

May 7, 2025
·
6 min read
Press Releases

Gilead’s Livdelzi® (Seladelpar) Demonstrated Consistent Efficacy and Safety Regardless of Prior Treatment History in New Data Presented at EASL 2025

May 7, 2025
·
14 min read
Press Releases

Monopar Presents ALXN1840 Late-Breaker Data at EASL 2025

May 7, 2025
·
4 min read